Hiding in Plain Sight Quantum computing has surged from theoretical curiosity to a transformative frontier, promising to ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...

Cadence Design Systems CDNS stock has rallied 23.8% over the past three months. The stock closed last trading session at $322 ...

Data center capital expenditures are reaching record highs. A significant portion of data center spending is allocated to ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside? May 27, 2025 — 10:00 am EDT. ... Image Source: Zacks Investment Research.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

BMY can make up ground with AI, however, as the company says the technology is "at the forefront" of its drug discovery and development. "Integrating AI across various functions, we enhance ...

Water molecules represent a powerful but largely underappreciated foothold in drug binding studies. See how ColdBrew, an algorithm designed by corresponding author Marcus Fischer, PhD (left) and first ...